A new Boston area startup has secured funding for next generation technology development. According to BioPharmaDive, “Morphic Therapeutic, a Waltham, MA-based startup, announced Thursday it has secured $51.5 million in Series A financing to develop integrin-blocking therapies.” For more information, please visit: http://www.biopharmadive.com/news/boston-startup-secures-515-million-in-race-for-next-gen-integrin-technolo/421888/